Clinical Trials · NCT05029076
Human Bioequivalence Test of Liraglutide Injection
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Enrollment
- 28
- Start date
- May 2019
- Locations
- 1 site, China
- Primary endpoint
- Maximum (peak) plasma drug concentration(Cmax)